At Aptus Biosciences, our mission is to drive innovation in aptamer technology and its applications.
We are committed to developing diagnostic solutions for neurology, oncology, cardiology, and infectious diseases.
The company’s innovative platform uses chemically modified DNA aptamers to create novel molecules poised to revolutionize early disease diagnosis and prognosis.